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groups.
RESULTS 922 patients with ULMCA disease were ﬁnally enrolled for
the analyses: 465 were treated with DES implantation and 457 with
CABG. During the median follow-up of 7.1 years (interquartile range
5.3 to 8.2 years), no difference was found between PCI and CABG in
the occurrence of death (adjusted hazard ratio [HR]: 0.791; 95% con-
ﬁdence interval [CI]: 0.516 to 1.212; p¼0.282) and the composite end
point of cardiac death, MI and stroke (adjusted HR: 0.825; 95% CI:
0.576 to 1.182; p¼0.294). Rates of major adverse cardiac and cere-
brovascular events were signiﬁcantly higher in the PCI group
(adjusted HR: 1.394; 95% CI: 1.070 to 1.817; p¼0.014), in large part
because of the signiﬁcantly higher rate of repeat revascular-
ization(adjusted HR: 2.368; 95% CI: 1.653 to 3.392; p < 0.001). PCI was
correlated with lower occurrence of stroke (adjusted HR: 0.348; 95%
CI: 0.171 to 0.707; p ¼ 0.004).
CONCLUSIONS During a median follow-up of 7.1 years (IQR 5.3 to 8.2
years), there was still no difference in rate of death between PCI with
DES implantation and CABG in ULMCA lesions in this single-center
experience. CABG group was observed to have signiﬁcantly lower
rates of repeat revascularization but higher stroke rates compared
with PCI.
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Recanalization of coronary chronic total occlusion and its effects on
myocardial perfusion and long term outcome
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OBJECTIVES The recanalization of the coronary chronic total occlu-
sion (CTO) is also not equal to the improved left ventricular function.
The present study will analyze what factors are contributing to suc-
cessful recanalization, the long term clinical outcomes and the effects
on myocardial salvage.
METHODS The patients who underwent coronary angiography (CAG)
from 2008 to 2013 were consecutively enrolled. The patients were
divided into 3 groups, the total occlusion and stenosis groups (group 1);
total occlusion myocardial perfusion group (group 2); CTO PCI
group (group 3). In the group 1 comparison was made between total
occlusion and high grade stenosis and the patients were followed for
the major adverse cardiovascular events. In the group 2 patients were
divided into total occlusion and stenosis. The SPECT summed rest
score, CAG indices (Syntax score, total MPG and MPGArea), echo-
cardiography indices (LVED and EF) were calculated. In the group 3,
559 CTO patients were divided into successful and unsuccessful
recanalization. The MPG, Bridge Point, Retrograde MPG, LVED and EF
were calculated.
RESULTS In the group 1, 253 total occlusion and 629 stenosis were
included. No difference in clinical characters was found between
total occlusion and stenosis except Syntax score. The MACE was
signiﬁcantly higher in total occlusion than in stenosis (P<0.05). No
difference in MACE among PCI, CABG and medicine treatments. In
the group 2 there were 111 patients who underwent SPECT and
CAG, of them 41 had total occlusion and 70 had stenosis. The total
occlusion had signiﬁcantly larger SRS, higher SYNTAX score,
reduced total MPG and MPGArea, enlarged LVED and reduced EF
(P<0.05). Stepwise multivariate analysis showed that the SRS were
independently correlated with EF, total occlusion and sex. In the
group 3, 559 CTO attempted PCI. The success rate was 67%.
Stepwise multivariate analysis showed age, unfavorite CTO and
higher J-score predicted unsuccessful recanalization. After suc-
cessful PCI there were 175 MPG2-3 and 99 MPG0-1. Low MPG
accounted for 36% and had low Bridge Point, low Retrograde MPG
and increased LVED (P<0.05). There were 190 Bridge Point 0-1 and
369 Bridge Point 2-3. Low Bridge Point accounted for 34%. After
PSmatch we found that low Bridge Point were correlated with
complex CTO, high J-score, Retrograde MPG, low EF and enlarged
LVED (P<0.05)
CONCLUSIONS Medication and CABG have similar clinical outcome
irrespective of CTO or stenosis. But CTO PCI may have poor clinical
outcome in comparison with stenosis. In CTO PCI the artery integrity
damage is more than stenosis. The myocardial perfusion and left
ventricular function are poor in the CTO patients. MPG, total MPG,
Bridge Point, EF and LVED are useful predictors of myocardial re-
covery after successful recanalization. Age, complex CTO and J-Score
are 3 main anatomic factors affecting recanalization. MPG and Bridge
Point help predict viability after recanalization.GW26-e1571
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OBJECTIVES 12-month dual antiplatelet therapy (DAPT) is recom-
mended after implantation of drug-eluting stents (DESs) in patients
with coronary heart disease. BUMA is a new drug-eluting stent with
two different functional coating layers, and More than 75 year old
patients have more complications like bleeding and gastrointestinal
intolerance. The time is not clear for elderly patients with BUMA
implantation.
METHODS We reviewed the data of 242 consecutive more than 75 year
old patients who had BUMA implantation four years ago and
completed 6-month DAPT. They were divided into two groups
randomly: 6-month and 12-month DAPT groups. The efﬁcacy (a
composite incidence of cardiac death, myocardial infarction and
target vessel revascularization) and safety (incidences of bleeding,
gastrointestinal trouble and drug discontinuation) were compared
with two groups.
RESULTS 242 patients included in the analysis, 118 were 6-month
DAPT group, 124were 12-month DAPT group. The mean follow-up
duration was 241.8 months after BUMA implantation. The age,
history of hypertension and stroke, BMI, SBP, DBP, high-density
lipoprotein-cholesterol (HDL-C), triglycerides (TG), fasting blood
glucose (FBG), estimated glomerular ﬁltration rate (eGFR), at baseline
did not differ signiﬁcantly between the two groups. The rates of multi-
vessel lesions, prior MI, hemoglobin A1C (HbA1c) and low-density
lipoprotein cholesterol were no difference signiﬁcantly in two groups.
There was no signiﬁcant difference in the overall composite incidence
of cardiac death, myocardial infarction and target vessel revasculari-
zation in two groups at one years after PCI. The rates of bleeding
(especially minor bleeding), gastrointestinal trouble, drug discontin-
uation and any blood transfusion were markedly lower in the 6-month
DAPT group than 12-month DAPT group (2.54%vs4.84%;4.24%
vs6.45%;5.09%vs8.06%;0.85%vs2.42%, P<0.05).
CONCLUSIONS 6-month DAPT may be more preferable to more than
75 year old patients who have undergone BUMA implantation,
because of it’s efﬁcacy and safety.GW26-e4527
The importance of serial measurement of platelet aggregation in long-term
dual antiplatelet therapy following drug eluting stent implantation
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OBJECTIVES Dual antiplatelet therapy (DAPT) and the response to
clopidogrel are two pivotal issues impacting on the use of drug-
eluting stents (DESs). Consequently, we analyzed the combined in-
ﬂuence of these factors to evaluate their long term effect in patients
undergoing DES implantation.
METHODS Platelet aggregation was serially measured by light trans-
mission aggregometry in all eligible patients during the course of
treatment with DAPT, and the mean platelet aggregation level of each
participant was calculated. Based on the duration of DAPT and the
mean platelet aggregation level, all the enrolled patients were then
divided into four groups. The primary endpoint was a composite of
all-cause death, nonfatal myocardial infarction (MI), stent thrombosis,
unexpected repeat revascularization, and stroke.
RESULTS We analyzed 1,245 suitable patients in this study. These
were divided into group A (12 month DAPT & low platelet aggregation
level) with 204 subjects, group B (>12 month DAPT & high platelet
aggregation level) with 419 subjects, group C (12 month DAPT & high
platelet aggregation level) with 289 subjects, and group D (>12 month
DAPT & low platelet aggregation level) with 333 subjects. Compared
with all other groups, group D was associated with a decreased inci-
dence of primary endpoints [HR 0.485, 95%CI (0.25–0.96); P ¼ 0.038].
When the Cox proportional hazards model was further tested with D
group as the reference category within the same group, groups B and C
were associated with increased incidence of primary endpoints [HR
2.26, 95%CI (1.10–4.68); P ¼ 0.0273] and [HR 2.31, 95%CI (1.03–5.18);
P ¼ 0.0413]. Their respective multivariate Cox proportional hazards
regressions conﬁrmed these trends.
